SVA – Page 33 – China Stock Advice

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Announces Director Appointment BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today the appointment of Mr. Meng Mei as an independent director to fill the vacancy created by the resignation of Ms. Chup Hung Mok. Mr. Mei has also been appointed as the chairman of Sinovac's compensation] [Sinovac's EV71 Vaccine Phase I Clinical Data for the Prevention of Epidemic Hand, Foot, Mouth Disease Published in Vaccine Vaccine BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that the positive Phase I clinical data for its proprietary inactivated Enterovirus 71 (EV71) vaccine against hand, foot and] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By info| 2016-03-24T01:19:10+00:00 April 6th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2012-04-06, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Director Appointment BEIJING, March 29, 2012

[Sinovac Announces Director Appointment BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today the appointment of Mr. Meng Mei as an independent director to fill the vacancy created by the resignation of Ms. Chup Hung Mok. Mr. Mei has also been appointed as the chairman of Sinovac's compensation] [Sinovac's EV71 Vaccine Phase I Clinical Data for the Prevention of Epidemic Hand, Foot, Mouth Disease Published in Vaccine Vaccine BEIJING, March 29, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that the positive Phase I clinical data for its proprietary inactivated Enterovirus 71 (EV71) vaccine against hand, foot and] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By info| 2016-03-24T01:20:47+00:00 April 6th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2012-04-06, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] SC 13G/A: (Original Filing)

[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]

By info| 2016-03-24T01:22:17+00:00 February 14th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2012-02-14, 2834, PHARMACEUTICAL PREPARATIONS, SC_13G.A, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement Press Release: Sinovac Biotech Co., Ltd. – Tue, Jan 24, 2012 4:05 PM EST BEIJING, Jan. 24, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based] [Sinovac Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease Press Release: Sinovac Biotech Ltd. – Tue, Jan 10, 2012 8:00 AM EST BEIJING , Jan. 10, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of biopharmaceutical products in China , announced today that the phase III clinical] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By info| 2016-03-24T01:24:57+00:00 February 6th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2012-02-06, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee

[Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement Press Release: Sinovac Biotech Co., Ltd. – Tue, Jan 24, 2012 4:05 PM EST BEIJING, Jan. 24, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based] [Sinovac Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease Press Release: Sinovac Biotech Ltd. – Tue, Jan 10, 2012 8:00 AM EST BEIJING , Jan. 10, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of biopharmaceutical products in China , announced today that the phase III clinical] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By info| 2016-03-24T01:26:07+00:00 February 6th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2012-02-06, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] SC 13G/A: (Original Filing)

[1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Royce & Associates, LLC 52-2343049 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York NUMBER OF 5 SOLE VOTING POWER SHARES 1,749,629 BENEFICIALLY 6 SHARED VOTING POWER OWNED BY]

By info| 2016-03-24T01:27:15+00:00 January 26th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2012-01-26, 2834, PHARMACEUTICAL PREPARATIONS, SC_13G.A, SVA|0 Comments

SVA [SINOVAC BIOTECH] SC 13G/A: 1 NAME OF REPORTING PERSON S.S. OR I.R.S.

[1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Royce & Associates, LLC 52-2343049 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York NUMBER OF 5 SOLE VOTING POWER SHARES 1,749,629 BENEFICIALLY 6 SHARED VOTING POWER OWNED BY]

By info| 2016-03-24T01:28:22+00:00 January 26th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2012-01-26, 2834, PHARMACEUTICAL PREPARATIONS, SC_13G.A, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Announces Resignation of Chup Hung Mok from Board of Directors Press Release: Sinovac Biotech Ltd. – Wed, Jan 4, 2012 8:00 AM EST BEIJING , Jan. 4, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China , today announced the resignation of Ms. Chup Hung Mok from its Board of Directors] [SINOVAC BIOTECH LTD. Weidong Yin Chairman and Chief Executive Officer]

By info| 2016-03-24T01:29:36+00:00 January 13th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2012-01-13, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Resignation of Chup Hung Mok from

[Sinovac Announces Resignation of Chup Hung Mok from Board of Directors Press Release: Sinovac Biotech Ltd. – Wed, Jan 4, 2012 8:00 AM EST BEIJING , Jan. 4, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China , today announced the resignation of Ms. Chup Hung Mok from its Board of Directors] [SINOVAC BIOTECH LTD. Weidong Yin Chairman and Chief Executive Officer]

By info| 2016-03-24T01:31:01+00:00 January 13th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2012-01-13, 2834, 6-K, PHARMACEUTICAL PREPARATIONS, SVA|0 Comments

SVA [SINOVAC BIOTECH] SC 13D/A: (Original Filing)

[SCHEDULE 13D CUSIP No. P8696W104 Page 2 of 6 Pages]

By info| 2016-03-24T01:32:29+00:00 December 30th, 2011|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2011-12-30, 2834, PHARMACEUTICAL PREPARATIONS, SC_13D.A, SVA|0 Comments